about
Epigenetic mechanisms of chronic painRevisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers.Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.Expression quantitative trait loci analysis of 13 genes in the rat prostate.Fidelity of the methylation pattern and its variation in the genome.Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis.A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2AEstablishment of a DNA methylation marker to evaluate cancer cell fraction in gastric cancer.Focus on gastric cancer.Diagnostic and therapeutic applications of epigenetics.Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epithelium.Visualization of multivalent histone modification in a single cell reveals highly concerted epigenetic changes on differentiation of embryonic stem cells.Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis.Degree of methylation burden is determined by the exposure period to carcinogenic factors.Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylationIdentification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.Systemic Administration of Small Interfering RNA Targeting Human Nestin Inhibits Pancreatic Cancer Cell Proliferation and Metastasis.Frequent involvement of chromatin remodeler alterations in gastric field cancerization.Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer.Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: aberrant DNA methylation pathway.DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis.Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction.Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas.The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae.Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.Roadmap for investigating epigenome deregulation and environmental origins of cancer.Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.Autophagy impairment by Helicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis.Promoter methylation profiling of 30 genes in human malignant melanoma.Establishment of a detection system for demethylating agents using an endogenous promoter CpG island.Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.Association of gastric cancer risk factors with DNA methylation levels in gastric mucosa of healthy Japanese: a cross-sectional study.Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells.
P50
Q27023688-4BD1C102-2EAB-4E2F-8397-9D3FC30A408DQ34219819-82A0C240-CC7C-4D2C-A597-625D3892EC5BQ34351731-9F503890-3EC0-41A0-986D-3C2840031CCBQ34441327-AE9FFD1B-9850-4C74-9A79-B7421AB02F99Q34538800-805964A1-0A7A-4FD7-8102-8AA62A7BF8FBQ34589899-9328BF14-D69F-4977-899B-358337E551FBQ35022067-CE36CE70-1256-4DD3-9033-B0B1042FC82AQ35023839-52D30F8B-FCA6-4362-B448-D054483C8EAAQ35163845-568D5D60-C36E-4194-B20E-E396BE4313D8Q35560360-F19B58B9-4A56-4EBD-A1E8-092F6722065CQ35681321-B0FD01EE-625B-4B12-B6D8-C3A4BEBD40ADQ36147536-583AD137-51B8-4C60-B470-17BFE8411261Q36287400-704FF070-B598-4E37-A839-EC0F21B7C8B1Q36444132-23311847-3640-4826-AA78-AF1CC561642CQ37122127-ED1797D4-A227-40CD-9D35-7643F3D0EE88Q37388548-E283D307-8AED-4CEF-B0D7-2DF6D5E4AD80Q37735664-3756F386-BDC3-4DB8-845C-548EB9495476Q37745916-27EDECAB-83D4-40AF-A522-322406A71DF2Q38704340-5E1B669F-E373-4FDF-A022-BC5FE904B919Q38838389-0FE8FB47-92C7-43CE-95D5-A88FA24B71A9Q38933269-EDA69393-151D-4DF8-925D-4544005D584EQ38951195-2AF7044B-CF7D-4DFD-989D-20A8668A186DQ38975542-6A37FC6C-EB08-409D-ABA4-95BABB2387EFQ38995210-E78D8AB4-0442-44F7-BEFD-3B3ABF3A3DE5Q39522418-6EA45CA0-3F22-4283-8199-9D3FD344847DQ39559400-D977EF33-F364-4CA3-8694-6A55F27D0EB8Q39912026-6441BC83-CDC4-427C-978C-4C426F2DB09DQ39973321-D21C8CD2-1D44-4365-AEDB-5962DBB9FEC3Q39996291-131A8B28-36D8-4292-8EF1-B456EFC0AA10Q40072626-822E5578-71A1-4A1B-9BBD-EDEB4E797ED3Q40156793-86382E00-490F-4771-8D72-361D76775A2DQ40327215-BDA25907-83E5-4129-8B89-BC1AB86DAB02Q40481342-4668D938-E779-4167-B41A-CB61319EC433Q40492543-CFC9DCA3-AE40-4D11-83A4-058352E8E9DDQ40506716-8DD0D5F5-6E97-4FBC-AF97-F77F6BDF4E95Q40507334-3481D06D-93B5-4066-AC84-03ECFD938B20Q40974815-24E2EA48-939F-469A-A103-EB339C8757AEQ41007869-0E2851E4-0D9B-4816-98B3-AC81D8258F89Q42271838-E84C6AD8-BD1A-4C85-909B-49D4B543D675Q42498478-BB9049FC-A044-4134-BF56-9A9C688D0EE5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Toshikazu Ushijima
@ast
Toshikazu Ushijima
@en
Toshikazu Ushijima
@es
Toshikazu Ushijima
@nl
type
label
Toshikazu Ushijima
@ast
Toshikazu Ushijima
@en
Toshikazu Ushijima
@es
Toshikazu Ushijima
@nl
prefLabel
Toshikazu Ushijima
@ast
Toshikazu Ushijima
@en
Toshikazu Ushijima
@es
Toshikazu Ushijima
@nl
P106
P1153
7102749551
P31
P496
0000-0003-3405-7817